RKVTF
PINK Rakovina Therapeutics Inc$0.1925 ↑ +0.0164 (+9.31%) Trading Up from the previous close of $0.1761, and at the day’s high of $0.1925
- YTD change
- +113.89%
- vs 20-day SMA
- N/A
- vs 200-day SMA
- N/A
Price ranges
Price & Performance
+0.12 (+167.36%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 30.6% away from all-time highs of $0.2773
- RKVTF is up 114% since the beginning of the year
- RKVTF is up 114% over the past 12 months
- RKVTF is up 114% over the past 1 month
- 0% of all RKVTF investors are betting against RKVTF
RKVTF reads n/a: the 12-month move is -19.4%.
- Previous minute
- +$0.0000
- Last hour
- +$0.0043
- Last 5 days
- +45.72%
- vs 8-day SMA
- +15.34%
No alerts for RKVTF in the last day.
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Rakovina Therapeutics, Inc. focuses on the development of new cancer treatments based on novel DNA-damage response technologies. It engages in developing precision medicines that selectively target and kill cancer cells using science to discover and advance innovative cancer treatments with the potential to improve patient outcomes across multiple tumor types. The company was founded on May 6, 2019 and is headquartered in Vancouver, Canada.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.